Listen Now

Topics Covered

• Overview of Waldenstrom’s Macroglobulinemia
• Symptoms & Signs
• Front Line Treatment for WM
• Treatment for Relapsed/Refractory WM
• Standard of Care & New Treatment Approaches
• Translating Genomic Findings into New Treatment Opportunities for WM
• The Role of Clinical Trials
• Symptom & Side Effect Management, including Reducing Complications
• Peripheral Neuropathy
• Communicating with Your Health Care Team about Your Quality-of-Life
• Mapping the Future of WM
• Questions for Our Panel of Experts

Our Panel of Experts

Jorge J. Castillo, MD

Clinical Director, Bing Center for Waldenstrom’s Macroglobulinemia, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Morie A. Gertz, MD, MACP

Consultant, Division of Hematology, Bone Marrow Transplant Program, Chair Emeritus Internal Medicine, Roland Seidler Jr. Professor Department of Medicine, College of Medicine, Mayo Distinguished Clinician, Mayo Clinic Rochester

Carl Harrington

President, IWMF - The International Waldenstrom’s Macroglobulinemia Foundation

Caroline Edlund, MSW

Online Support Group Program Director, CancerCare

Brochure

You can download the brochure for this workshop(176 KB)

Workshop Date

This workshop was originally recorded on June 27, 2018.